These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33723389)

  • 1. RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.
    Paramasivam A; Priyadharsini JV
    Br J Cancer; 2021 May; 124(10):1621-1622. PubMed ID: 33723389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of m6A RNA methylation in cancer.
    Sun T; Wu R; Ming L
    Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine links RNA metabolism to cancer progression.
    Dai D; Wang H; Zhu L; Jin H; Wang X
    Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-mediated m
    Chen X; Gong W; Shao X; Shi T; Zhang L; Dong J; Shi Y; Shen S; Qin J; Jiang Q; Guo B
    Ann Rheum Dis; 2022 Jan; 81(1):87-99. PubMed ID: 34706873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
    Xiang M; Liu W; Tian W; You A; Deng D
    Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
    [No Abstract]   [Full Text] [Related]  

  • 10. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
    Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
    Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA methylation patterns, immune characteristics, and autophagy-related mechanisms mediated by N6-methyladenosine (m6A) regulatory factors in venous thromboembolism.
    Zhang D; Fu W; Zhu S; Pan Y; Li R
    BMC Genomics; 2024 Apr; 25(1):403. PubMed ID: 38658847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
    Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
    J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
    Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
    Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.